Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Model System Using Percutaneous Biopsy Samples

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal malignant tumor and more than 50% patients are diagnosed at metastatic stage. The preclinical model systems that reflect the genetic heterogeneity of metastatic tumors are urgently needed to guide optimal treatment. This study describes the...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Sun Il, Jeon, A-Ra, Kim, Min Kyeong, Lee, Yu-Sun, Im, Ji Eun, Koh, Jung-Wook, Han, Sung-Sik, Kong, Sun-Young, Yoon, Kyong-Ah, Koh, Young-Hwan, Lee, Ju Hee, Lee, Woo Jin, Park, Sang-Jae, Hong, En Kyung, Woo, Sang Myung, Kim, Yun-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753223/
https://www.ncbi.nlm.nih.gov/pubmed/31572675
http://dx.doi.org/10.3389/fonc.2019.00875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753223/
https://www.ncbi.nlm.nih.gov/pubmed/31572675
http://dx.doi.org/10.3389/fonc.2019.00875

Ejemplares similares